Proof-of-concept Study for BIVV020 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy Intervention: Drug: BIVV020 Sponsor: Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2020 Category: Research Source Type: clinical trials
Subcutaneous Immunoglobulin in De-novo CIDP (SIDEC)
Condition: CIDP - Chronic Inflammatory Demyelinating Polyneuropathy Intervention: Biological: Immunoglobulin Sponsors: University of Aarhus; Rigshospitalet, Denmark; Aarhus University Hospital; Odense University Hospital; Aalborg University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2020 Category: Research Source Type: clinical trials